We also found that life-threatening COVID-19 patients possessing neutralizing antibodies against IFN-α2 and/or IFN-ω tended to be elderly males, a pattern consistent with observations made with other patient populations [16, 19, 22, 23, 36, 37]. The gene discussed is IFNA2; the disease is COVID-19.